Form 8-K - Current report:
SEC Accession No. 0001193125-21-192088
Filing Date
2021-06-16
Accepted
2021-06-16 16:01:29
Documents
2
Period of Report
2021-06-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d169767d8k.htm 8-K 38666
2 EX-3.1 d169767dex31.htm EX-3.1 5384
  Complete submission text file 0001193125-21-192088.txt   45295
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 211021432
SIC: 2834 Pharmaceutical Preparations